Andrew Mazar
Oprichter bij Actuate Therapeutics, Inc.
Vermogen: 2 $ op 30-04-2024
Profiel
Andrew P.
Mazar is the founder of Lung Therapeutics LLC (2012), Tactic Pharma LLC (2010), and Monopar Therapeutics, Inc. (2014).
He held the title of Director & Chief Scientific Officer at Monopar Therapeutics, Inc. (2014-2022).
Dr. Mazar is also the founder of ProBility Media Corp., Tempus, Inc., Wilson Therapeutics, Inc., Avidtox, Inc., and Valence Therapeutics, Inc. Dr. Mazar's current job is at the National Heart, Lung & Blood Institute where he has been a Member since 2011.
Dr. Mazar's former jobs include being the Chairman-NCI Nanotechnology Alliance at the National Cancer Institute (2011-2015) and Chief Scientific Officer at Attenuon, LLC (2000-2009).
He was also a Member at the Chemistry of Life Processes Institute.
Dr. Mazar obtained a doctorate degree from the University of Illinois College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. 0.48% | 01-05-2024 | 184 354 ( 0.48% ) | 2 $ | 30-04-2024 |
Actieve functies van Andrew Mazar
| Bedrijven | Functie | Begin |
|---|---|---|
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Oprichter | 16-01-2015 |
| National Heart, Lung & Blood Institute | Corporate Officer/Principal | 01-01-2011 |
Eerdere bekende functies van Andrew Mazar
| Bedrijven | Functie | Einde |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Oprichter | 08-04-2022 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01-01-2015 |
| Attenuon, LLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
| Valence Therapeutics, Inc. | Oprichter | - |
| Avidtox, Inc. | Oprichter | - |
Opleiding van Andrew Mazar
| University of Illinois College of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MONOPAR THERAPEUTICS INC. | Health Technology |
| PROBILITY MEDIA CORPORATION | Commercial Services |
| Bedrijven in privébezit | 10 |
|---|---|
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Health Technology |
| Attenuon, LLC | |
Tactic Pharma LLC
 Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Commercial Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| National Heart, Lung & Blood Institute | Government |
| Wilson Therapeutics, Inc. | |
Tempus, Inc.
 Tempus, Inc. Beverages: Non-AlcoholicConsumer Non-Durables Part of FormCap Corp., Tempus, Inc. is a company that produces bottled beverages. The company is based in Sarasota, FL. The company was founded by Andrew P. Mazar. The CEO is Mauricio Naranjo Gonzalez. Tempus was acquired by FormCap Corp. on May 12, 2000. | Consumer Non-Durables |
| Avidtox, Inc. | |
| Valence Therapeutics, Inc. |
